Novocure

Novocure is an oncology company pioneering a novel therapy for solid tumors called Tumor Treating Fields, or TTFields.
Novocure stock price chart
vol.
change
P/E
Net profit
P/B
Book value
P/FCF
FCF
Yield
Growth potential

Novocure balance sheet

Report period2018 2019 2020 2021 20222023
End date of the reporting period
Capitalization, $
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

Novocure cash flows

Report period2018 2019 2020 2021 20222023
End date of the reporting period
Sales
Gross profit
Operation Income
Earnings
Shareholders earnings
EBITDA
Adjusted EBITDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS

Novocure multipliers

Report period2018 2019 2020 2021 20222023
P/E
E/P
P/B
P/S
P/FCF
L/A
Debt-To-Equity
Net Debt/EBITDA
Net Debt/EBITDA adj.
EV/EBITDA
EV/EBITDA adj.

Novocure profitability

Report period2018 2019 2020 2021 20222023
ROA
ROE
ROS
Gross margin
EBITDA Margin
Operating margin
Novocure assets
Novocure cash flows

Novocure shares

TickerNameTypeNominal valueISINPrice
NVCR:USNovocureCommon share-JE00BYSS4X48$16.11
Novocure news
28.04.2022
Novocure's GAAP loss for 3 months of 2022 was $4.647 million, up 12.6% from $4.128 million in the prior year. Revenue increased 2.1% to $137.547 million from $134.695 million a year earlier.
Source: novocure.com pictogram novocure.com
Pictogram next
24.02.2022
Novocure's GAAP loss for 2021 was $58.351 million, compared to a profit of $19.808 million in the previous year. Revenue increased 8.2% to $535.031 million from $494.366 million a year earlier.
Source: novocure.com pictogram novocure.com
Pictogram next
28.10.2021
Novocure's GAAP loss for 9M 2021 was $31.893 million, compared to a profit of $14.891 million in the previous year. Revenue increased 14.7% to $401.818 million from $350.413 million a year earlier.
Source: novocure.com pictogram novocure.com
Pictogram next
29.07.2021
Novocure's GAAP net income for the six months of 2021 was $18.769 million, up 3.3 times from $5.607 million in the previous year. Revenue increased 23.2% to $268.212 million from $217.753 million a year earlier.
Source: novocure.com pictogram novocure.com
Pictogram next
All Novocure news
General information
Company nameNovocure
Tags#medtech
SectorHealth Care / Health Care Equipment & Services / Health Care Equipment & Supplies / Health Care Equipment
Business addresse Masurier House La Rue Le Masurier Saint Helier, JE2 4YE Jersey, Channel Islands
Websitewww.novocure.com
Information disclosurewww.sec.gov